Related Experiment Video For basal cell carcinoma
Updated: May 1, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011
Catherine M Olsen1, Patricia F Williams2, David C Whiteman1
1Cancer Control Group, Population Health Department, QIMR Berghofer Medical Research Institute, Queensland, Australia.
Background:
Keratinocyte cancers (basal cell carcinoma, squamous cell carcinoma) are the commonest cancers in human beings. Population data on incidence trends are scant because few jurisdictions reliably record diagnoses or treatments.
Objective:
We sought to examine temporal trends of treating keratinocyte cancers in Australia.
Methods:
We analyzed Medicare Australia data relating to the diagnosis and treatment of keratinocyte skin cancer between 2000 and 2011. We examined counts and rates for each procedure, and the average annual percentage rate of change.
Results:
There were significant increases in excision rates for keratinocyte cancers (3.3% per annum for men and 2.2% per annum for women), however temporal trends differed significantly by age group. Although annual increases in excision rates were highest for men aged 75 to 84 years (8.6% per annum), they declined significantly for men and women younger than 45 years. Skin biopsy rates increased substantially in all age groups over the study period, suggesting no lessening in skin cancer surveillance in any age group.
Limitations:
The Medicare data do not include services provided in public hospitals, however fewer than 2% of skin cancers are treated in these settings.
Conclusions:
Although overall treatment rates for keratinocyte cancers have increased substantially during the past decade, excision rates are declining in younger Australians.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

